BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
2 hedge funds and large institutions have $1.13M invested in BriaCell Therapeutics Corp Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.37% less ownership
Funds ownership: 3.19% → 2.82% (-0.37%)
8% less capital invested
Capital invested by funds: $1.22M → $1.13M (-$92.8K)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
-$111K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$351 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $938K | – | – | – |
|
|
RAM
2
Redmond Asset Management
Henrico,
Virginia
| $188K | – | – | – |
|
|
SFA
3
Sequoia Financial Advisors
Akron,
Ohio
| – | -$111K | -45,000 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$351 | -142 | Closed |
|
BCTXW Hedge Fund Activity: Q4 2023 in Review
2 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q4 2023, worth a combined $1.13M — down 7.6% from $1.22M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BCTXW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sequoia Financial Advisors, exiting entirely with an estimated $111K sold.
- 2 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q4 2023, down from 4 in Q3 2023.
- Funds reported $1.13M of BriaCell Therapeutics Corp Warrant stock for Q4 2023, down 7.6% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest BriaCell Therapeutics Corp Warrant seller in Q4 2023 was Sequoia Financial Advisors, an estimated $111K sold.
Based on aggregated 13F filings for Q4 2023.